Stock Analysis
Avantor, Inc.AVTR
Sector: Technology · Industry: Laboratory Analytical Instruments
AnalystsHold25 analystsPrice is 100% of the way from the year's low to its high.
Cash covers 8% of debt · Q2 2026.
PMP Verdict
Weak fundamentals
Strengths
- Quality60
Risks
- Growth0
- Profitability17
Weak fundamentals — valuation is the only support.
Market context
+2.1% today· Z 1.1σ· RVOL 3.5×
What's happening with AVTR
Profile
growth, profitability and moat lag behind.
How is each axis scored?
- Valuation52/100 · Moderate
- P/E vs own history (n/a)10/25
- FCF yield (4.1%)12/25
- P/S (1.7x)25/25
- EV/EBIT (27.6x)5/25
- Growth0/100 · Weak
- Revenue CAGR (-3.0%)0/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (n/a)0/25
- Profitability17/100 · Weak
- ROIC (4.6%)5/25
- ROE (-10.3%)0/25
- Net margin (-8.8%)0/25
- Operating margin (8.0%)12/25
- Financial Health50/100 · Moderate
- Altman Z (1.79)10/25
- Current ratio (1.78)18/25
- Interest coverage (2.7x)10/25
- Net cash / debt (D/A 29%)12/25
- Quality60/100 · Moderate
- Piotroski F (4/9)10/25
- Beneish M (-2.94)25/25
- FCF conversion (-79%)0/25
- Margin stability (σ 3.1%)25/25
- Moat38/100 · Weak
- ROIC >12% years (0/7 yrs)0/25
- Median gross margin (33.6%)13/25
- FCF-positive years (7/7 yrs)25/25
- Worst-year net margin (worst -8.1%)0/25
Risk Flags
- ⚠Altman Z 1.8 — distress-zone balance sheet
- ⚠Interest coverage 2.7× — thin debt cushion
- ⚠Revenue shrinking 3.0%/yr
About Avantor, Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Show more
The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Headquarters: RADNOR, PA · Employees: 13,500 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
52CP/E (TTM)—
Price / TTM EPS (own statements)
P/FCF24.1xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield4.1%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 3.5%–10.4% · 14th pct
P/S (TTM)1.69xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.8x–3.7x · 32nd pct
EV/EBIT27.6xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 9.8x–52.8x · 51st pct
EV/Sales2.2xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E20.2xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio1.98xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio—
Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
17EROIC4.6%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE-10.3%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA-5.0%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin-8.8%D
Grade D: LowNet Income / Revenue
Operating Margin8.0%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin31.8%C
Grade C: AverageGross Profit / Revenue
FCF Margin6.9%D
Grade D: LowFCF / Revenue
True FCF Margin6.3%C
Grade C: AverageTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
0ERevenue CAGR-3.0%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth—
Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)+14.6%D
Grade D: DilutiveShare count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.6%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
50CAltman Z-Score1.79D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.78xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.18xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage2.7xD
Grade D: RiskyEBIT/Interest. >10 Strong
Debt Repayment7.5yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT6.4xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity0.66xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.08xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
60BPiotroski F-Score4/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.94A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion-78.7%D
Grade D: PoorFCF / Net Income
Margin Stability3.1%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue2.2%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.56xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Garner Todd W Filed | Garner Todd W | Grant / award | +138.6K | |
Garner Todd W Filed | Garner Todd W | Grant / award | +49.7K | |
Ligner Emmanuel Filed | Ligner Emmanuel | Tax withholding | -29803 | |
Hankamer Brittany Filed | Hankamer Brittany | Tax withholding | -181 | |
Eck Steven W Filed | Eck Steven W | Tax withholding | -1385 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Sokenu Claudius Filed | Sokenu Claudius | Tax withholding | -1201 | |
Walker Corey Filed | Walker Corey | Tax withholding | -3010 | |
LUCIER GREGORY T Filed | LUCIER GREGORY T | BuyOpen market buy | +10.0K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
38DROIC >12% Years0/7 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)33.6%C
Grade C: ModerateMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years7/7 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor-8.1%D
Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)—
TTM net income per share (Finnhub fallback)
Cash / Share$0.45
Cash & short-term investments per share (Finnhub)
Book Value / Share$8.32
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$3.70B
Total debt obligations (short + long term)
Cash & Equiv.$306.80M
Cash and short-term investments
Net Debt$3.39B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$5.63B
Shareholders' equity (book value)
Asset / Liability1.94xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$11.12B
Current Market Capitalization
Beta0.98B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Avantor, Inc. (AVTR)
AVTR is up 2.05% at the last close. Piotroski F-Score of 4/9 indicates mixed fundamentals for Avantor, Inc.. Altman Z-Score of 1.79 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of -2.94 suggests a low likelihood of earnings manipulation.
- Revenue has been contracting (CAGR ≈ -3%), which weighs on the growth outlook.
- Takes ~7.5 years to repay net debt from free cash flow.
- Avantor, Inc. posted a net loss in 1 of 7 available completed fiscal years (2019–2025).
See how AVTR ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for AVTR in the last 30 days.
See AVTR move history →Frequently Asked Questions about AVTR
What is the current Avantor, Inc. (AVTR) stock price?
AVTR is trading at $16.42 at the last market close, up 2.05% on the session. PreMarketPrice tracks AVTR pre-market, intraday and after-hours prices.
Is AVTR stock a buy right now?
PreMarketPrice's quantitative model rates Avantor, Inc.'s financial health at 50/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is AVTR stock overvalued?
Avantor, Inc. trades at a trailing P/E of n/a and our valuation score rates it 52/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Avantor, Inc. report earnings?
No confirmed earnings date is currently scheduled for AVTR. The Earnings section lists recent reports and updates as dates are announced.
What sector does Avantor, Inc. operate in?
Avantor, Inc. operates in the Technology sector, within the Laboratory Analytical Instruments industry. The Related Stocks section lists sector peers for comparison.
What does Avantor, Inc. do?
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
About Avantor, Inc. (AVTR) Stock
Avantor, Inc. (AVTR) is a US-listed stock operating in the Technology sector, specifically the Laboratory Analytical Instruments industry. As of the latest update, Avantor, Inc. is trading at $16.42, up 2.05% on the day with a market capitalization of $11.1 billion. The financial health score for AVTR is 50/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for AVTR stock.
AVTR Stock Analysis & Key Metrics
On PreMarketPrice, you can track Avantor, Inc. (AVTR) across multiple dimensions:
- Pre-market price & movement: Real-time AVTR stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for AVTR with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Avantor, Inc. across multiple reporting periods.
- Financial health score: A composite score of 50/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for AVTR.
- Sector peers: Compare AVTR against 6 other technology stocks on key financial metrics.
Is AVTR a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Avantor, Inc. (AVTR) as an investment. The financial health score of 50/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Avantor, Inc. (AVTR) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.